AdCare Rhode Island Welcomes Community to Free Educational Event on the Use of Medications to Treat Addiction

NORTH KINGSTOWN, R.I., Jan. 21, 2025 (GLOBE NEWSWIRE) — In response to Rhode Island's ongoing addiction and overdose crisis, AdCare Rhode Island, a leading provider of substance use and co-occurring disorder treatment in New England, will be hosting a free community event on medication-assisted treatment (MAT). In 2023 alone, more than 400 people in the […]

Kingsway Publishes Updated Investor Presentation to Company Website

CHICAGO, ILLINOIS / ACCESS Newswire / January 21, 2025 / (NYSE:KFS) Kingsway Financial Services Inc. ("Kingsway" or the "Company") today announced that a new investor presentation has been published to the Company’s website. The presentation, which provides an overview of the Company’s business, industry, financials and other relevant information, can be accessed and downloaded by

Recon Infosec Partners with SideChannel to Offer More Comprehensive Cybersecurity Solutions

WORCESTER, MA / ACCESS Newswire / January 21, 2025 / Recon Infosec and SideChannel (OTCQB:SDCH) are excited to announce a new partnership, which gives Recon Infosec’s clients access to SideChannel’s virtual Chief Information Security Officer (vCISO) services and gives SideChannel’s clients access to Recon’s Managed Security Operations services. Through this collaboration, Recon’s clients can tap

Tiger Finance Posts Record Growth in Fiscal 2024

Lending platform supports acquisition and transitional capital needs of a wide array of U.S. retailers, wholesalers and tech firms. Tiger Finance's lending platform committed more than a quarter of a billion dollars in Fiscal 2024 to support the growth initiatives and working capital needs of borrowers from across the U.S. economy. Loan volume grew throughout

Change Must Begin at the Top: Barington Capital Sends Letter to Matthews International Shareholders Highlighting its Director Nominees’ Substantial CEO Experience, Relevant Sector Expertise and Deep Commitment to Shareholder Value Creation

Barington Capital Believes Electing Ana Amicarella, Chan Galbato and James Mitarotonda to the Matthews Board Will Best Position the Board to Unlock the Value Embedded Within the Company Current Board is Radically Entrenched, Long Tenured and Incapable of Holding Management Accountable for 18 Years of Value Erosion Urges Shareholders to Vote the GOLDProxy Card “FOR”the

Domino’s® Announces Fourth Quarter/Year-End 2024 Earnings Webcast

Domino's Pizza, Inc. (Nasdaq: DPZ) announces the following event: https://mma.prnewswire.com/media/1309392/Dominos_Large_Logo.jpg What: Domino's Fourth Quarter/Year-End 2024 Earnings WebcastWhen: Monday, February 24 at 8:30 a.m. ETWhere: ir.dominos.comHow: Live webcast (web address above)Contact: Greg Lemenchick, Vice President of Investor Relations investorrelations@dominos.com This event will be archived on Domino's website for replay. Results and supplemental material will be distributed

United Airlines Achieves Record Fourth Quarter Profit Well Ahead Of Expectations; Reiterates Path To Double-Digit Pre-Tax Margin

Q4 pre-tax margin up 3.2 points year-over-year, 3.5 points on an adjusted basis1 Finished the year first in on-time departures at all seven United hubs Sees robust demand in the first quarter 2025 as industry transformation is well underway United Airlines (UAL) today reported full-year and fourth-quarter 2024 financial results. The company had full-year pre-tax

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

(NasdaqGM:IRON), WATERTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it has commenced an underwritten offering of $200.0 million of shares of its common stock and,

Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report – Hagens Berman

REGN Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / January 21, 2025 / Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024, wiping out about $9 billion of market value. Hagens Berman has opened an investigation

Scroll to Top